Breaking News Instant updates and real-time market news.

CARA

Cara Therapeutics

$18.90

1.21 (6.84%)

09:29
04/24/19
04/24
09:29
04/24/19
09:29

Cara Therapeutics management to meet with Cantor Fitzgerald

Meeting to be held in Baltimore on April 24 hosted by Cantor Fitzgerald.

  • 24

    Apr

CARA Cara Therapeutics
$18.90

1.21 (6.84%)

01/02/19
PIPR
01/02/19
NO CHANGE
PIPR
Piper calls Horizon top 2019 growth idea in Specialty Pharmaceuticals
Piper Jaffray analyst David Amsellem calls Horizon Pharma (HZNP) his top "growth oriented/GARP idea" for 2019. The company offers high asset quality, visibility into significant longer-term EBITDA growth, and manageable debt levels that enable significant business development flexibility, Amsellem tells investors in a research note. He believes the Specialty Pharmaceuticals group is well positioned to perform more in-line with the broader therapeutics and overall healthcare spaces in 2019, or "certainly better than what we have seen in recent years." The analyst names Bausch Health (BHC), a stock he upgraded this morning to Overweight, his top "de-leveraging/defensive pick" for 2019. Further, Amsellem's top "development-stage picks" for 2019 are Cara Therapeutics (CARA) and Revance Therapeutics (RVNC).
01/15/19
BOFA
01/15/19
INITIATION
Target $19
BOFA
Neutral
Cara Therapeutics initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Gerberry initiated Cara Therapeutics with a Neutral and $19 price target saying shares reflect maximum probability for lead asset IV Korsuva in Phase 3 for pruritus.
02/06/19
JEFF
02/06/19
INITIATION
Target $22
JEFF
Buy
Cara Therapeutics assumed with a Buy at Jefferies
Jefferies analyst Chris Howerton assumed coverage of Cara Therapeutics with a Buy rating and $22 price target. The analyst is optimistic on Korsuva, the company's "peripherally restricted, highly selective, and potent" kappa opioid receptor agonist that is being developed for pruritic indications.
04/08/19
STFL
04/08/19
NO CHANGE
Target $26
STFL
Buy
Cara could rise 'well past the mid-$20s' on good KALM-1 data, says Stifel
Stifel analyst Annabel Samimy noted that Cara Therapeutics should be reporting its first pivotal readout of Phase 3 KALM-1 data for CKD-associated pruritus in the hemodialysis population within weeks and she believes the share "could move well past the mid-$20s" on a positive outcome. The analyst, who applies a 75% probability of success to Korsuva in CKD-associated pruritus, keeps a Buy rating and $26 price target on Cara shares and would be a buyer ahead of the data.

TODAY'S FREE FLY STORIES

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:46
06/25/19
06/25
17:46
06/25/19
17:46
Hot Stocks
FedEx says international commercial team still poised for growth »

Says TNT Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:43
06/25/19
06/25
17:43
06/25/19
17:43
Hot Stocks
FedEx says global trade picture 'less than ideal' »

Says "all-in"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:38
06/25/19
06/25
17:38
06/25/19
17:38
Hot Stocks
FedEx calls FY20 a 'transition year' »

Says FY20 a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

CNX

CNX Resources

$6.83

-0.345 (-4.81%)

17:36
06/25/19
06/25
17:36
06/25/19
17:36
Hot Stocks
CNX Resources director Bernard Lanigan purchases 36,200 shares of company stock »

CNX Resources director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:32
06/25/19
06/25
17:32
06/25/19
17:32
Hot Stocks
TechnipFMC confirms settlement with U.S., Brazilian enforcement authorities »

TechnipFMC has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

MO

Altria Group

$48.80

0.31 (0.64%)

, BTI

British American Tobacco

$35.76

0.56 (1.59%)

17:25
06/25/19
06/25
17:25
06/25/19
17:25
Periodicals
San Francisco votes to ban sale of e-cigarettes, AP reports »

San Francisco, California…

MO

Altria Group

$48.80

0.31 (0.64%)

BTI

British American Tobacco

$35.76

0.56 (1.59%)

PM

Philip Morris

$78.85

1.02 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$53.69

0.57 (1.07%)

17:16
06/25/19
06/25
17:16
06/25/19
17:16
Recommendations
CVS Health analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:15
06/25/19
06/25
17:15
06/25/19
17:15
Hot Stocks
TechnipFMC, subsidiary to pay $296M to resolve foreign bribery charges »

TechnipFMC and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

ORRF

Orrstown Financial

$21.93

0.22 (1.01%)

17:11
06/25/19
06/25
17:11
06/25/19
17:11
Hot Stocks
Orrstown Financial names Thomas Brugger EVP and CFO »

Orrstown Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
Hot Stocks
Micron says it has mitigated 90% of China tariff impact »

Says U.S. tariffs on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AGN

Allergan

$162.60

32.95 (25.41%)

, ABBV

AbbVie

$65.63

-12.78 (-16.30%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks muddled through a…

AGN

Allergan

$162.60

32.95 (25.41%)

ABBV

AbbVie

$65.63

-12.78 (-16.30%)

TMUS

T-Mobile

$74.56

-0.98 (-1.30%)

S

Sprint

$6.82

-0.04 (-0.58%)

DISH

Dish

$37.80

-0.79 (-2.05%)

LEN

Lennar

$48.24

-3.17 (-6.17%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

UPS

UPS

$97.11

-2.58 (-2.59%)

FB

Facebook

$188.87

-3.69 (-1.92%)

PYX

Pyxus

$17.06

3.635 (27.09%)

GRUB

GrubHub

$76.01

3.96 (5.50%)

ALDX

Aldeyra

$6.21

-0.87 (-12.29%)

W

Wayfair

$144.54

-7.925 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 16

    Sep

  • 13

    Nov

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:05
06/25/19
06/25
17:05
06/25/19
17:05
Hot Stocks
AIT Therapeutics plans to file PMA submission with FDA for PPHN with AirNOvent »

On track to file a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:03
06/25/19
06/25
17:03
06/25/19
17:03
Earnings
Micron sees Q4 EPS 45c +/- 7c, consensus 78c »

Sees Q4 revenue $4.5B +/-…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:00
06/25/19
06/25
17:00
06/25/19
17:00
Earnings
AIT Therapeutics reports Q4 EPS (49c), consensus 28c »

Reports Q4 revenue $7.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

16:48
06/25/19
06/25
16:48
06/25/19
16:48
Hot Stocks
Micron says it can resume shipping a certain subset of products to Huawei »

Says expects healthy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

16:42
06/25/19
06/25
16:42
06/25/19
16:42
Hot Stocks
AeroVironment down 9.5% to $55.50 after Q4 results, FY20 guidance »

The midpoint of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BBVA

Banco Bilbao

$5.52

-0.05 (-0.90%)

16:40
06/25/19
06/25
16:40
06/25/19
16:40
Syndicate
Breaking Syndicate news story on Banco Bilbao »

Banco Bilbao files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

CRTO

Criteo

$18.00

-0.05 (-0.28%)

16:39
06/25/19
06/25
16:39
06/25/19
16:39
Hot Stocks
Criteo COO Mollie Spilman to leave company »

Criteo S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.68

0.17 (0.56%)

16:37
06/25/19
06/25
16:37
06/25/19
16:37
Hot Stocks
Kraft Heinz accelerates new CEO start date to June 25 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$144.12

-5.99 (-3.99%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Periodicals
Spotify chief revenue officer Brian Benedik to depart, The Information reports »

Spotify's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/25/19
06/25
16:34
06/25/19
16:34
General news
API crude inventories for week of June 21 »

API reports that crude…

GBCI

Glacier Bancorp

$39.23

-0.06 (-0.15%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Hot Stocks
Glacier Bancorp raises dividend to 27c from 26c »

Glacier Bancorp declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NSRGY

Nestle

$0.00

(0.00%)

, NVS

Novartis

$92.37

-0.41 (-0.44%)

16:33
06/25/19
06/25
16:33
06/25/19
16:33
Periodicals
Nestle, Novartis among multinationals at risk of London trading ban, WSJ says »

Trading in…

NSRGY

Nestle

$0.00

(0.00%)

NVS

Novartis

$92.37

-0.41 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DRRX

Durect

$0.67

0.0422 (6.72%)

16:31
06/25/19
06/25
16:31
06/25/19
16:31
Hot Stocks
Durect receives approval to transfer to Nasdaq Capital Market »

Durect Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.